Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice.

Furlan R, Brambilla E, Sanvito F, Roccatagliata L, Olivieri S, Bergami A, Pluchino S, Uccelli A, Comi G, Martino G.

Brain. 2003 Feb;126(Pt 2):285-91.

PMID:
12538398
3.

Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.

Zou J, Yao Z, Zhang G, Wang H, Xu J, Yew DT, Forster EL.

J Neurol Sci. 2008 Sep 15;272(1-2):87-98. doi: 10.1016/j.jns.2008.05.003. Epub 2008 Jun 19.

PMID:
18571202
4.

Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice.

Bach P, Tschäpe JA, Kopietz F, Braun G, Baade JK, Wiederhold KH, Staufenbiel M, Prinz M, Deller T, Kalinke U, Buchholz CJ, Müller UC.

J Immunol. 2009 Jun 15;182(12):7613-24. doi: 10.4049/jimmunol.0803366.

5.

Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells.

Monsonego A, Imitola J, Zota V, Oida T, Weiner HL.

J Immunol. 2003 Sep 1;171(5):2216-24. Erratum in: J Immunol. 2004 Jan 1;172(1):717.

6.

Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease.

Monsonego A, Imitola J, Petrovic S, Zota V, Nemirovsky A, Baron R, Fisher Y, Owens T, Weiner HL.

Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5048-53. Epub 2006 Mar 20.

7.

CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.

Teige A, Teige I, Lavasani S, Bockermann R, Mondoc E, Holmdahl R, Issazadeh-Navikas S.

J Immunol. 2004 Jan 1;172(1):186-94.

8.

Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.

Geylis V, Steinitz M.

Autoimmun Rev. 2006 Jan;5(1):33-9. Epub 2005 Aug 1. Review.

PMID:
16338209
9.
10.

Immunotherapy for Alzheimer's disease.

McGeer PL, McGeer E.

Sci Aging Knowledge Environ. 2004 Jul 7;2004(27):pe29.

PMID:
15243154
11.

Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.

Matsuda J, Kaminaka K, Nozaki C.

Biochem Biophys Res Commun. 2009 Apr 24;382(1):149-52. doi: 10.1016/j.bbrc.2009.02.153. Epub 2009 Mar 3.

PMID:
19265678
12.

T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease.

Fisher Y, Nemirovsky A, Baron R, Monsonego A.

PLoS One. 2010 May 26;5(5):e10830. doi: 10.1371/journal.pone.0010830.

13.

Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice.

Sohn JH, So JO, Kim H, Nam EJ, Ha HJ, Kim YH, Mook-Jung I.

Biochem Biophys Res Commun. 2007 Sep 28;361(3):800-4. Epub 2007 Jul 27.

PMID:
17678618
14.

Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).

Crawford FC, Wood M, Ferguson S, Mathura VS, Faza B, Wilson S, Fan T, O'Steen B, Ait-Ghezala G, Hayes R, Mullan MJ.

Brain Res. 2007 Dec 14;1185:45-58. Epub 2007 Sep 25.

PMID:
17961517
15.

Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice.

Seabrook TJ, Iglesias M, Bloom JK, Spooner ET, Lemere CA.

Vaccine. 2004 Sep 28;22(29-30):4075-83.

PMID:
15364459
16.

Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.

Tan SL, Zhao J, Bi C, Chen XC, Hepburn DL, Wang J, Sedgwick JD, Chintalacharuvu SR, Na S.

J Immunol. 2006 Mar 1;176(5):2872-9.

17.
18.

CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide.

Townsend KP, Town T, Mori T, Lue LF, Shytle D, Sanberg PR, Morgan D, Fernandez F, Flavell RA, Tan J.

Eur J Immunol. 2005 Mar;35(3):901-10.

19.

Anti-Abeta: The good, the bad, and the unforeseen.

Broytman O, Malter JS.

J Neurosci Res. 2004 Feb 1;75(3):301-6. Review.

PMID:
14743443
20.

Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies.

Montero E, Nussbaum G, Kaye JF, Perez R, Lage A, Ben-Nun A, Cohen IR.

J Autoimmun. 2004 Aug;23(1):1-7.

PMID:
15236747

Supplemental Content

Support Center